KNDM:一个知识图转换器和节点类别敏感对比学习模型用于药物和微生物协会预测
Dongliang Chen1, Tiangang Zhang2, Hui Cui3
1School of Mathematical Science, Heilongjiang University, Harbin 150080, China.
Journal of chemical information and modeling
|April 23, 2025
概括
新的KNDM模型通过整合知识图和对比学习,准确地预测与药物相关的微生物,改善药物疗效的理解. 这种方法通过考虑各种实体特征和元路径关系来增强预测.
科学领域:
- 计算生物学和生物信息学
- 药理学和药物发现
- 微生物组研究的研究.
背景情况:
- 人类微生物组显著影响药物的疗效和毒性.
- 准确识别与药物相关的微生物对于理解药物机制至关重要.
- 目前用于药物微生物预测的图形学习方法在利用多种实体特征和元路径上下文关系方面存在局限性.
研究的目的:
- 提出一种新的模型,即KNDM,该模型解决了当前药物-微生物关联预测的局限性.
- 增强知识图形特征和元路径上下文关系的利用,以提高预测准确度.
- 开发一种方法,确保实体特征和节点语义特征之间的一致性.
主要方法:
- 构建一个全面的知识图,整合药物和微生物实体.
- 开发一个对实体类别敏感的变压器来处理实体异质性和关系.
- 实现一个元路径语义特征学习策略与递归门.
- 应用一个节点类别敏感的对比学习策略来提高特征一致性.
主要成果:
- 拟议的KNDM模型显著优于八种最先进的药物-微生物关联预测模型.
- 除研究证实了KNDM核心创新的有效性,包括变压器和对比学习组件.
- 案例研究表明,KNDM能够识别黄素,表甲基酸盐和西普罗夫洛克萨等药物的潜在关联.
结论:
- 通过有效利用知识图表和先进的学习技术,KNDM提供了一个可靠的框架来预测药物和微生物的关联.
- 该模型能够整合多样化的特征和上下文信息,从而带来卓越的预测性能.
- KNDM为推进个性化医学研究和理解药物-宿主-微生物相互作用提供了有价值的工具.
更多相关视频
03:37Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
Published on: March 1, 2024
1.5K
05:47Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
1.9K
相关概念视频
Drug Discovery: Overview
7.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.2K
Drug Nomenclature
1.5K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.5K
Drug Classes and Categories
1.8K
Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
1.8K
Drug Biotransformation: Overview
2.2K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.2K
Combined Effects of Drugs: Antagonism
8.1K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.1K
Combined Effects of Drugs: Synergism
3.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.6K
